Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves mRESVIA (respiratory syncytial virus vaccine) for Prevention of Lower Respiratory Tract Disease Caused by RSV

CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA...

FDA Approves Onyda XR (clonidine hydrochloride) Non-Stimulant Liquid Treatment for ADHD

May 29, 2024 – Business Wire – Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity...

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma

(BUSINESS WIRE) May 30, 2024 -- Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) has granted approval for...

Two Key Steps to Curbing Your Tween's Screen Time

Parents frustrated with kids who are seemingly glued to their phones, take heart: New research finds you can tear them away from their devices.Two approaches...

FDA Panel Says No to MDMA as Treatment for PTSD

A U.S. Food and Drug Administration advisory panel on Tuesday voted against recommending the psychedelic MDMA for the treatment of post-traumatic stress...

Transplanted Pig Kidney Is Removed From Woman Who Received It

A woman who was the second person to ever receive a kidney from a genetically modified pig has had the transplanted organ removed due to complications...

CDC Supports Use of Antibiotic as 'Morning After Pill' to Stop STDs

In new guidelines released Tuesday, U.S. health officials now recommend that certain people take the antibiotic doxycycline as a morning-after pill to...

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

SOUTH SAN FRANSCISO, Calif., June 04, 2024. Surrozen, Inc. (“Surrozen” or the “Company”), a company pioneering targeted therapeutics...

ASCO: Stepped-Care Model Noninferior to Early Palliative Care for Advanced Cancer

For patients with advanced lung cancer, a stepped-care model with palliative care visits occurring at key points in patients' cancer trajectory is noninferior...

Excess Mortality Persisted in Western World From 2020 Through 2022

Excess mortality persisted in 2020 through 2022 in the Western world, according to a study published online June 3 in BMJ Public Health.Saskia Mostert,...

Coworker, Organizational Support Increase Nurses' Intent to Stay at Job

Coworker and employer support are strong predictors that nurses plan to stay in their jobs, according to a study published online May 31 in the Online...

Staying Up Late Tied to Poorer Mental Health

Going to bed late, regardless of natural inclination, is associated with poorer mental health, according to a study published online May 19 in Psychiatry...

Indaptus Therapeutics Announces New Positive Data from Ongoing Phase 1 Trial of Decoy20

NEW YORK, June 03, 2024. Indaptus Therapeutics, Inc, a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection...

What Is a Cerebral Aneurysm? What Are the Signs?

Cerebral aneurysms: For most people, the word signals a sudden, fatal brain bleed that seemingly comes out of nowhere. However, an expert at Penn State...

Monthly News Roundup - May 2024

FDA Clears GSK’s Benlysta Autoinjector for Systemic Lupus Erythematosus (SLE) in Children In May, the U.S Food and Drug Administration (FDA) cleared...

U.S. FDA Acknowledges Astellas' Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has acknowledged...

Read more news...

Recently Added

Recently added consumer and prescribing information: mRESVIA, Bkemv, Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • mRESVIA mRESVIA is a modified RNA vaccine that may protect adults aged 60 years and older from lower respiratory tract disease caused by an RSV infection.
  • Onyda XR Onyda XR (clonidine hydrochloride) is a once-daily, extended-release, oral suspension that may be used to treat...
  • Bkemv Bkemv (eculizumab-aeeb) is a complement inhibitor interchangeable biosimilar to Soliris for the treatment of paroxysmal nocturnal...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development